Active Ingredient(s): Cabotegravir + Rilpivirine
FDA Approved: * January 21, 2021
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cabenuva Overview

Cabotegravir/rilpivirine, sold under the brand name Cabenuva, is a co-packaged antiretroviral medication for the treatment of HIV/AIDS.[2][3][4][5] It contains cabotegravir and rilpivirine in a package with two separate injection vials.[2][3][5] The most common adverse reactions include injection site reactions, fever or feeling hot (pyrexia), fatigue, headache, musculoskeletal pain...

Read more Cabenuva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cabenuva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cabotegravir + Rilpivirine
  • Suspension, Extended Release: 400mg/2ml (200mg/ml) + 600mg/2ml (300mg/ml), 600mg/3ml (200mg/ml) + 900mg/3ml (300mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cabenuva: (2 results)

Sorted by National Drug Code
  • 49702-240 CabenuvaCabenuva Kit by Viiv Healthcare Company
  • 49702-253 CabenuvaCabenuva Kit by Viiv Healthcare Company

Drugs with one or more similar ingredients: (11 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA